lfa102
Castration-resistant Prostate Cancer, Advanced Breast Cancer
Novartis PharmaceuticalsPhase 1
—
Rating in progress
lfa102 in Castration-resistant Prostate Cancer, Advanced Breast Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant